CRP and neoplasm: Consequently, those patients in the present study with an elevated CRP and an increased plasma fibrinogen level might have a lower MIB-1 labeling index due to a higher number of M1 phenotype macrophages, which can act as tumoricidal cells via phagocytosis, promoting inflammation, releasing cytotoxic cytokines, and impeding the tumor growth [50,51].